chr6-36474790-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173562.5(KCTD20):c.162C>A(p.Asp54Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000129 in 1,599,256 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173562.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KCTD20 | NM_173562.5 | c.162C>A | p.Asp54Glu | missense_variant, splice_region_variant | 3/8 | ENST00000373731.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KCTD20 | ENST00000373731.7 | c.162C>A | p.Asp54Glu | missense_variant, splice_region_variant | 3/8 | 1 | NM_173562.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152150Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000135 AC: 33AN: 244432Hom.: 0 AF XY: 0.000129 AC XY: 17AN XY: 132190
GnomAD4 exome AF: 0.000131 AC: 189AN: 1446988Hom.: 0 Cov.: 31 AF XY: 0.000111 AC XY: 80AN XY: 718090
GnomAD4 genome AF: 0.000112 AC: 17AN: 152268Hom.: 0 Cov.: 31 AF XY: 0.0000940 AC XY: 7AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.162C>A (p.D54E) alteration is located in exon 3 (coding exon 2) of the KCTD20 gene. This alteration results from a C to A substitution at nucleotide position 162, causing the aspartic acid (D) at amino acid position 54 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at